Category Archives: Financial

Sharon Lechter, Co-Author of Best-selling Rich Dad Series Serves as Keynote Speaker During Uganda’s 6th Annual Financial Literacy Week

International best-selling author, entrepreneur, advocate and speaker, Sharon Lechter, will serve as a keynote speaker for the Sixth annual Financial Literacy Week in Kampala, Uganda, to be held from September 28th through October 1st, 2011.

Scottsdale, AZ, Thursday – September 22, 2011 — International best-selling author, entrepreneur, advocate and speaker, Sharon Lechter, will serve as a keynote speaker for the Sixth annual Financial Literacy Week in Kampala, Uganda, to be held from September 28th through October 1st, 2011.

A passionate advocate of financial education, Lechter has focused her efforts on developing tools to inspire families and children to create security and build wealth. As founder of Pay Yourself First, LLC, ( http://payyourfamilyfirst.com ) and co-founder and former CEO of the Rich Dad Company, Lechter’s earned continued acclaim for her work. She co-authored the popular Rich Dad Poor Dad series; and most recently, in conjunction with the Napoleon Hill Foundation, released two new books in the Think and Grow Rich series: Three Feet from Gold and Outwitting the Devil.

Uganda’s Financial Literacy Week is an annual event tasked with creating public awareness regarding finances. The mission includes promoting financial discipline such as saving and investing. The ultimate goal is to eradicate the cycle of poverty, ensuring sustainable intergenerational wealth and financial freedom.

“It doesn’t matter what language they speak, or what currency they use, parents everywhere want their children to succeed. The need for financial literacy is a global issue and I applaud Uganda for leading the charge in providing financial education to its young people. It is an honor and a privilege to participate in the Sixth Annual Financial Literacy Week,” said Lechter.

This year organizers plan to target a variety of public service professionals including teachers, nurses, students, uniformed officers, and women groups, and will conclude with a breakfast Saturday for business leaders and diplomats.

Martin D. Muhwezi, Managing Director of the Investors Club, LTD. in Kampala, said, “Financial Literacy is the ability to make informed judgments and effective decisions regarding the use and management of money. It is a life skill that every income earner or potential income earner needs to achieve their financial goals, and live a financially comfortable life.”

Welcoming Lechter with enthusiasm, Muhwezi said, “We plan to launch Financial Literacy clubs in high schools here in Uganda next year, and want to partner with Sharon to donate materials we can use to teach African youth and children the principles of money management.”

Lechter will share the podium with her husband, Michael Lechter, a leading intellectual property U.S. attorney, certified licensing professional and university professor and best-selling author, who served as an advisor to the original Rich Dad series.

Formerly a partner in the international law firm of Squire, Sanders & Dempsey, LLP, Michael is an Adjunct Professor at Arizona State University, and a lecturer at Thunderbird School of Global Management. Together with Sharon, the two own a number of small businesses, including the acclaimed Cherry Creek Lodge ( http://cherrycreeklodge.com ).

Upon return from Uganda, Lechter will continue to dedicate herself to promoting the message of empowered personal success outlined in, Outwitting the Devil.

Press & Media Contact:
Scott Kelly
Black Dog Promotions
9920 S. Rural Rd., Ste 108
Tempe AZ, 85284 – USA
480-206-3435
scott@blackdogpromotions.com
http://www.blackdogpromotions.com
http://cherrycreeklodge.com
http://payyourfamilyfirst.com

Carrentals.co.uk: Don’t Chance Not Reporting Penalty Points to Insurers

03 August 2011 – Online car hire price comparison website Carrentals.co.uk is advising the UK’s drivers not to cut corners in seeking out ways to save on car insurance this year. The award-winning website, which is home to cheap car hire deals in over 15,000 locations, advises drivers to always announce penalty points on their licences to insurers.

With UK car insurance costs continuing to be higher than ever, some drivers look to reduce their premiums by not making insurers aware of penalty points and accidents they have been previously involved with. However many drivers don’t know that they are legally bound to report such facts to their insurance company.

Having been involved in an accident or incident in the past and not reporting it means that the driver can be left helpless should the insurance company decide not to pay out on a claim. In addition the driver is then also left driving without insurance under a void cover policy – also illegal under UK law.

Gareth Robinson, Managing Director of Carrentals.co.uk, says: “There is no doubt that car insurance is really expensive these days so we are in a way not surprised that people would seek to lower their outgoings however possible. Not telling an insurer about previous points is inadvisable though.”

“People at this time need to know that should they be involved in an accident under a void insurance policy through not announcing points, they will risk incurring extra costs – paying for other people’s cars, medical bills, legal fees and such. Points on a licence and also big fines can be levied too – so holding back that penalty points information in the first place can end up costing people more money if and when they get caught out.”

Carrentals.co.uk is the leading car hire comparison site providing cheap car hire by comparing deals from up to 50 rental companies, including Alamo, Auto Europe, Budget, Holiday Autos and Sixt, in over 15,000 locations worldwide including car hire in Spain, USA and Switzerland, with a wide choice of pickup locations including car hire in Malaga, Denver and Geneva.

www.carrentals.co.uk.
/ends.

About Carrentals.co.uk
Carrentals.co.uk was launched in February 2003 and grew to become one of the UK’s leading online car hire companies by 2006.

In 2007 the company re-launched its site to create the first major online price comparator in the travel industry. Using the latest technology the Carrentals.co.uk site now searches up to 50 different car hire websites, providing an impartial comparison of the best prices available in over 15,000 locations.

Websites searched include Alamo, Auto Europe, Budget, Ebookers, Hertz, Holiday Autos, Opodo, Sixt and Thrifty, with the Carrentals.co.uk site quickly comparing prices and allowing customers to refine their search by car type.

The Carrentals.co.uk site also features over 5,000 pages of travel information in a mini-guide format.

In 2008 Carrentals.co.uk was voted Best Car Hire Website in the Travolution Awards, and in 2010 it was Highly Commended in the Best Meta-search/Price Comparison category. To book or for further information visit www.carrentals.co.uk

Media Contact
Rachel Builder & Jenny White
Context
T: 01625 511966
F: 01625 511967
carrentals@contextpr.co.uk
www.contextpr.co.uk

Contact Details: Helen Young
press@asapventures.co.uk
ASAP Ventures Ltd
0844 448 1489
www.carrentals.co.uk

###

 

CTS Releases New Mac OSX Compatible Drivers for Document Reader and Scanner

Ivrea (To), Italy – May 3, 2011 – CTS electronics, a world leading supplier of OEM products and solutions for banking, retail and public administration market sectors, adds new features to its product portfolio by developing New Mac OSX Compatible Drivers for Apple Macintosh Users.

CTS’ products designed for Remote Deposit Capture (RDC) are now also available to the growing Apple Macintosh Market that until now, could not take advantages from RDC solutions. The new interface allows implementation of all the features and functionality already available on the existing Windows and Linux operating systems APIs.

CTS’ series of LS scanners offers a wide range of communication and software compatibility with  Windows 2000, XP, Vista, 7 (32/64 bit), Linux and now MAC OSX; supportability for TWAIN drivers and Silver Bullet Ranger, along with its own common API; and connectivity with the IP addressable LSConnect add-on device – offering both PC and MAC users the widest range of operating systems support.

Since its foundation, CTS electronics has a history of delivering the best solutions to meet Market Demands. The Apple Macintosh Interface is another implementation of the Full Function Products Range which makes CTS electronics a Company Leader in Worldwide Document Processing Systems.

Apple, Macintosh, Mac OSX are registered trademarks of Apple Inc.

About CTS

CTS is a leading global manufacturer of solutions for tellers, back offices, self-service systems and retail point-of-sale counters with three decades of growth, experience, and innovation. CTS’ main strength is the fast-cycle design of innovative products for financial and corporate customers and self-services solution providers, as well as financial card embossers/printers and government ID solutions.
Today, CTS is a reliable ISO9000 quality certified company, it has more than 240 employees, based in Italy, USA and UK and has over 1 million end-user banking peripherals installed across five continents.
For more information please visit www.ctsgroup.it or call (+39) 0125.235.611

###

Pickfords Launches New Insurance Comparison Website

Pickfords, one of the UK’s leading removal and storage companies add to their existing portfolio of services by launching a home contents insurance comparison website.

London, England, May 4th 2011 – Pickfords one of the best known removals and storage companies launch a brand new home contents insurance comparison website in order to provide their customers with a wide choice of options at the point of moving home.

Russell Start, Managing Director, says, “Moving home is a great time to consider reviewing your home contents insurance. We know our customers assess the value of their goods prior to moving home. We aim to make the process as easy as possible and to help our customers save money and time by connecting them to some great offers that are not available on the open market.”

Pickfords has negotiated a range of discounts and offers with insurance providers and can connect its customers to offers for home and contents insurance, lettings property insurance and vacant property insurance.

Russell Start goes onto say, “Home contents insurance can be a thing that is easily overlooked when moving house but has the potential to be a very costly oversight. By drawing customers attention to our recently launched home contents insurance comparison website we hope that they will take advantage of the special discounts on offer or at least help them remember to renew/amend their existing policy.”

An insurance quoting engine has been created on the Pickfords website so customers can log in, fill out a simple form and the engine searches for the best deals negotiated by Pickfords. Pickfords customers can also request a call from an expert to discuss their particular circumstances and requirements.

Russell Start concludes by saying, “In common with the removals and storage side of our business, our ultimate aim is 100% customer satisfaction with the new service we are offering and what better time to think about home content insurance than at the point of moving home?”

Pickfords, the UK’s largest moving and storage company provides a portfolio of services to a diverse range of clients. Their new home contents insurance comparison website can be found at www.pickfords-insurance.co.uk

For further information, please contact:

Contact Person: Lyndsey Daykin
Mail: lyndsey.daykin@pickfords.com
Phone: 0777 4456607

MLDEX Market Development Training Program

18 July 2011 – /RTPR/ – The Market Development Training Program hosted by the Headquarters of the MLDEX, was held in Melbourne, Australia in the week of 12-19 June 2011.

This program was designed as a forum for the exchange of best practices in the development and regulation of capital markets presented through a series of lectures, roundtables and case studies. Senior experts from different International Regulatory Agencies and the Capital Markets Board (CMB), as well as speakers from the region shared their insights on capital market development, enforcement, and examination of market participants. The Program also explored responses to crises and market abuses, provided observations comparing and contrasting approaches by regulatory systems around the world, and highlighted international best practices.

The presenters used real-world examples of market abuse and inefficiencies to explore the regulatory, statutory, and other tools that capital market regulators need to address.

Besides CMB representatives, many international exchange representatives and market professionals attended the event that was also sponsored by MLDEX.

Contact Details: Melbourne Derivatives Exchange
Bourke Place,
Bourke Street 600,
Melbourne, 3000
Victoria, Australia
www.mldex.com

###

Instant Pink Slip Loans Provides Instant Service to Car Buyers

Company Quickly Delivers Bigger Loans at Competitive Interest Rates Direct to Buyer’s Door.

Tarzana, CA, Thursday – June 30, 2011 — Instant Pink Slip Loans ( http://www.InstantPinkSlipLoans.com ) announced today they are offering a new type of auto title loan service for car buyers. Using Manheim Marker Report (MMR) values, Instant Pink Slip Loans will provide buyers with title loans that are up to 120 percent of the vehicle’s value. The unique difference between their loan service and other car title loan services is that customers can apply for the loan online, or over the telephone any time of the day or night, and have the check and contract conveniently delivered to the location of their choice by a notary public.

“In the community and for the community,” says Gregory Plotkin, president of Instant Pink Slip Loans. Plotkin also emphasizes that the company uses MMR values, instead of the standard Kelly Blue Book prices, to determine the amount of the loan they would approve for the car buyers. “Manheim’s calculations are based on over 10 million sales transactions over the previous 13 months, which provides precise pricing unmatched by guide books. This allows customers to get more money for the car they want to use as collateral”.

Instant Pink Slip Loans, Gregory Plotkin, Company President states, currently allows customers to get cash for cars in California, Arizona, South Carolina, and New Mexico. In all states except California, the minimum loan amount buyers would qualify for is $1,500 and the maximum is $50,000. In California, the minimum loan amount for secured title loans is $2,510.

Interest rates are competitive with other financial institutions that offer secured loans and loan terms range from 24 months to 48 months. Buyers can apply for the loan by telephone or over the Internet and be approved in as little as 60 seconds. There is no pre-payment penalty and there are bad credit secured loans available for customers with credit challenges.

To apply for a Pink Slip Loan, also known as a Car Title Loan or an Auto Title Loan, customers can call any time of the day or night 877-846-2624 or apply online at http://www.InstantPinkSlipLoans.com.

About Instant Pink Slip Loans:
Instant Pink Slip Loans offers car owners an easy way to obtain a car title loan with very competitive interest rates, flexible payments, and great service. Instant Pink Slip Loans also provides its customers with the fastest loan approval time. Customers get pre-approved in 60 seconds and have the check delivered right to their front door.

Press & Media Contact:
Gregory Plotkin, President
Instant Pink Slip Loans
18340 Ventura Blvd
Tarzana, CA 91356 – USA
877-846-2624
InstantPinkSlipLoans@yahoo.com
http://www.InstantPinkSlipLoans.com

Reliable Solutions announce the launch of the Reliable FX Signals subscription service

May 17, 2011 /RTPR/ – After almost 3 years of trading, development and back-testing, Reliable Solutions is proud to announce the launch of the Reliable FX Signals subscription service.

For the first time ever, Reliable Solutions introducing “Automated Trading System” in Forex industry. By this service, subscribers need not to wait for email or SMS to receive trade signals. Instead of that all the trade signals will automatically executed on subscribers Metatrader 4 account. All subscriber need to do is to check increasing balance daily.

Each day, Reliable FX Signal subscribers will be sent at least 1 trading signal a day. If subscribers PC and Internet are online then that trade will be executed automatically and it will also set take profit, stop loss levels at the time of execution. Reliable FX Signal will also manage risk of subscribers account. We also offer 100% money back guarantee to our subscribers. It means, at the end of the month if subscribers account balance stays below of beginning balance then we will give 100% subscription charges back to subscriber. Development of own profitable, stable, viable trading system may take several years. Normally, this process faces some dangers. Plus add to that the fact that you are going to make some big mistakes on your way which means that you will lose lots of money. Often, these mistakes devastate the account, and injure the incentives of the beginner so much, that he gives up his work with Forex and makes no further tries. Our signals will help you avoid this huge mistake.

Our experienced and professional traders strive to identify the market current trend (short or long) ¬ so you can reap the benefits and make money constantly. We hope that you will take full advantage of all we have to offer in our website.

For more information about the signal subscription service, Reliable FX Signals, you can go to the company website at http://www.reliablefxsignals.com

Contact Details: admin@reliablefxsignals.com

Advanced Cell Technology has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo

May 10, 2011 /RTPR/– Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.

• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Advanced Cell Technology has been granted by the US Food and Drug Administration (FDA) a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells for both Stargardt’s Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world and Dry Age-Related Macular Degeneration (AMD) the most common form of macular degeneration in the world affecting an estimated 150 million people. ACT is using RPE cells developed from the patented (SCB) technique for this trial. The trial will take place at UCLA’s Jules Stein Eye Institute in California. Because of the biological nature of the human eye the trial will be able to provide a 100% irrefutable proof that the (hESC) derived RPE cells used attached to the Bruch’s membrane. Before and after state of the art imaging will take place.

Raymond Lund, Ph.D., a scientific collaborator with ACT, and considered one of the world’s foremost experts in retinal cell physiology and vision restoration, commented, “The study results of ACT’s RPE cells implanted in the various animal models of macular degeneration was phenomenal. If ACT observes even a fraction of that benefit in humans, it will be nothing short of a home run.”

FDA validation will occur for (hESC) medicine in less than 12 months. Will those that dictate law and morality to others lead? Will those suffering from disease all over the world finally have conclusive proof that (hESC) work? Life is filled with multifaceted choices and in a rare occurrence a quantum leap shows itself to the world. Human flight, computers and now regenerative medicine.

Disclosure: Stem Cell Media LLC nor its Companies was compensated by “any” entity for this article.www.investorstemcell.com is bringing investors and stakeholders together to participate in the world’s only online discussion forum dedicated to regenerative medicine.

Contact Details: icell@investorstemcell.com
www.investorstemcell.com

###

NASDAQ:GERN & OTC:ACTC – A David & Goliath Comparison

May 09, 2011 /RTPR/– Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements:http://www.sec.gov/Archives/edgar/data/1140098/000101376211000631/form10k.htm

If you are looking for maximum possible ROI in the short term and can tolerate high risk, then maybe Advanced Cell Technology (OTC:ACTC) is for you? If ACT is validated by the FDA, the (RPE) MA-09 “embryo-safe” cell lines would open up an annual $25,000,000,000.00 market treating (AMD). Yes that is (b) with an (illion) annual market share! No FDA approved treatment exist for (AMD) in the world. This disease effects 30 million in the USA & EU alone. Cell lines have potential to treat 200 retinal eye diseases. ACT has been approved for U.S. Orphan Drug status protection for (SMD). This status by the FDA provides ACT seven years of market protection. ACT is expecting EU-Orphan Drug status for (SMD) and if awarded would receive 10-years of market protection. The recent patent protection for ACT’s RPE cells in China firmly establish potential world dominance of the (AMD) market. What is the down side? One glaring red flag is that ACT has two years of operating capital and enough cash to fund both the SMD/AMD Phase-1/2 trials in the U.S. If ACT’s AMD/SMD trials are not validated, ACT would most likely be forced to institute a massive reverse split due to the O/S nearing its A/S. ACT has placed all of its eggs in one pipeline basket, choosing the low hanging fruit model. ACT is counting on the exceptional Casey Eye Clinic animal results. Dr. Raymond Lund Ph.D., considered one of the world’s foremost experts in retinal cell physiology and vision restoration. Dr. Lund recently said the following: “The study results of ACT’s RPE cells implanted in the various animal models of macular degeneration was phenomenal. If ACT observes even a fraction of that benefit in humans, it will be nothing short of a home run.”

Disclosure: www.investorstemcell.com is the world’s only online discussion forum dedicated bringing investors & stakeholders together in thoughtful discussion about stem cell & regenerative medicine. www.investorstemcell.com nor any of its Companies have been compensated by “any” party for this article. Before making an investment decision an investor should perform due diligences. Once completed find out what the street thinks at www.investorstemcell.com

Contact Details: www.investorstemcell.com
icell@investorstemcell.com

###

SmartCo opens London Office

London, May 5, 2011
SmartCo announces its continued international expansion with the opening, in May 2011, of a London office to support its growing operations in the UK and Northern European markets.
SmartCo has seen an increase in the number of its international clients and as part of its internationalisation strategy, the Paris and Boston-based software company’s goal is to be present in the world’s leading financial centers, in order to best support its clients through such local presence. The establishment of operations in London will allow SmartCo to react quickly and efficiently to customer-led demand and coincides with an increased sales and account management footprint in the UK and Northern European markets.
Pascal Mougin, SmartCo’s CEO, comments: “We are very excited to have established a formal presence in London. By opening an office in the UK, we will ensure that we continue to provide the highest level of service and dedication to the UK and Northern European markets. SmartCo is fully committed to meeting the diverse needs of each of these marketplaces. While we are already the market leader in France and have achieved remarkable success in other countries around the globe, the UK has always been one of our most important target markets, as it has for any financial software company. Our presence in London will certainly influence our ability to further penetrate and understand the needs and requirements of our clients and prospects.”
About SmartCo:
Since 2004, SmartCo has helped financial institutions of all sizes to optimise their data management capabilities with a state-of-the-art software solution, the SmartCo DataHub. SmartCo is a fast growing and dynamic international company with its main headquarters in Paris, North American headquarters in Boston, a new office in London and consulting and integration partners in several North American and European cities.
Innovation and flexibility is our motto: In addition to the centralisation of securities and counterparties reference and market data and the ability to fully cover the operational data needs for any financial institution, SmartCo DataHub allows its clients’ core data management processes to seamlessly evolve with their business and market needs without any constraints from the software vendor.
Please feel free to contact our new London office at:
SmartCo
88 Wood Street
London EC2V 7RS
United Kingdom
+44 (208) 528 1531
For additional information about SmartCo, go to http://www.smartco.com or email us at info@smartco.com